ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Reminds Innate Pharma S.A. Buyers of Vital December 22 Deadline in Securities Class Motion – IPHA | State

0
49
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action - IPHA | State

NEW YORK, December 15, 2020 / PRNewswire / – Rosen Law Firm, a global investor rights law firm, is reminding buyers of the stocks of Innate Pharma SA (NASDAQ: IPHA) between March 10, 2020 and September 8, 2020including (the “class period”) the important December 22, 2020 Lead plaintiff deadline in the company’s first securities lawsuit. The lawsuit seeks to seek compensation for innate investors under federal securities laws.

To participate in the Congenital Class Action Lawsuit, go to http://www.rosenlegal.com/cases-register-1763.html or call Phillip Kim, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for information about the class action.

According to the lawsuit, throughout the classroom, defendants made false and / or misleading statements and / or failed to disclose that: (1) innately touted the results of their various Phase 2 trials as expected; (2) Innate continued to assure investors that it would be for the $ 100 million Pay at first dose of Phase 3 trials; (3) Innate did not timely announce its renegotiations with AstraZeneca to split the contract $ 100 million Payment in two parts $ 50 million Payments partially dependent on performance during Phase 3 studies; and (4) as a result, Defendants’ statements about Innate’s business, business and prospects were materially false and misleading and / or had no reasonable basis at all relevant times. When the real details hit the market, the lawsuit alleged that investors suffered damage.

A class action lawsuit has already been filed. If you want to stand as the lead plaintiff, you must move the court not later than December 22, 2020. A lead plaintiff is a representative party who acts on behalf of other class members in directing the dispute. To join the litigation, visit http://www.rosenlegal.com/cases-register-1763.html or contact to discuss your rights or interests in relation to this class action lawsuit Phillip Kim, Esq. the law firm Rosen free of charge at 866-767-3653 or by email at [email protected] or [email protected]

NO CLASS HAS BEEN CERTIFIED IN THE ABOVE PROMOTION. Until a class is certified, you will not be represented by the advisor unless you keep one. You can keep the advice of your choice. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. An investor’s ability to get involved in a potential future recovery does not depend on being the lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https: // www. facebook .com / rosenlawfirm /.

Rosen law firm represents investors around the world and focuses on class action and shareholder derivatives litigation. Rosen law firm was ranked # 1 by ISS Securities Class Action Services for number of class action settlements in 2017. The firm has been voted one of the top 3 every year since 2013. The Rosen law firm has filed its largest class action lawsuit ever for securities against a Chinese company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and reputable sources. Rosen law firm has raised hundreds of millions of dollars for investors. Lawyer advertising. Previous results do not guarantee a similar result.

Contact information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen, PA law firm
275 Madison Avenue, 40th floor
New York, NY 10016
Tel .: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com